Inhibition of Cyclin-Dependent Kinase Phosphorylation of FOXO1 and Prostate Cancer Cell Growth by a Peptide Derived from FOXO1

by Lu, Huarui, Liu, Ping, Pan, Yunqian, Huang, Haojie
Published 2011

Protein B23/Nucleophosmin/Numatrin nuclear dynamics in Relation to Protein Kinase CK2 and Apoptotic Activity in Prostate Cells

by Wang, Guixia, Pan, Yunqian, Ahmad, Kashif A., Ahmed, Khalil
Published 2010

Combinations of N-Acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-Inositol Inhibit Tobacco Smoke Carcinogen-induced Lung Adenocarcinoma in A/J Mice

by Kassie, Fekadu, Matise, Ilze, Negia, Mesfin, Lahti, David, Pan, Yunqian, Scherber, Robyn, Upadhyaya, Pramod, Hecht, Stephen S.
Published 2008

Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells

by Jiang, Jingting, Pan, Yunqian, Regan, Kevin M., Wu, Changping, Zhang, Xueguang, Tindall, Donald J., Huang, Haojie
Published in Prostate (2011)

FOXO1 Binds to the TAU5 Motif and Inhibits Constitutively Active Androgen Receptor Splice Variants

by Bohrer, Laura R., Liu, Ping, Zhong, Jian, Pan, Yunqian, Angstman, James, Brand, Lucas J., Dehm, Scott M., Huang, Haojie
Published 2013

Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression

by Yang, Jing, Jin, Xin, Yan, Yuqian, Shao, Yingjie, Pan, Yunqian, Roberts, Lewis R., Zhang, Jun, Huang, Haojie, Jiang, Jingting
Published in Sci Rep (2017)

FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion

by Zhang, Haijun, Pan, Yunqian, Zheng, Li, Choe, Chungyoul, Lindgren, Bruce, Jensen, Eric D., Westendorf, Jennifer J., Cheng, Liang, Huang, Haojie
Published 2011

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer

by Wu, Changping, Jin, Xin, Yang, Jing, Yang, Yinhui, He, Yundong, Ding, Liya, Pan, Yunqian, Chen, Shuai, Jiang, Jingting, Huang, Haojie
Published in Oncotarget (2015)

AKT‐phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1‐MAPK interaction

by Pan, Chun‐Wu, Jin, Xin, Zhao, Yu, Pan, Yunqian, Yang, Jing, Karnes, R Jeffrey, Zhang, Jun, Wang, Liguo, Huang, Haojie
Published in EMBO J (2017)

Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1–MAPK Interaction

by Jin, Xin, Pan, Yunqian, Wang, Liguo, Ma, Tao, Zhang, Lizhi, Tang, Amy H., Billadeau, Daniel D., Wu, Heshui, Huang, Haojie
Published in Cancer Res (2017)

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2

by Chen, Shuai, Bohrer, Laura R., Rai, Aswathy N., Pan, Yunqian, Gan, Lu, Zhou, Xianzheng, Bagchi, Anindya, Simon, Jeffrey A., Huang, Haojie
Published 2010

P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth

by Gang, Xiaokun, Yang, Yinhui, Zhong, Jian, Jiang, Kui, Pan, Yunqian, Karnes, R. Jeffrey, Zhang, Jun, Xu, Wanhai, Wang, Guixia, Huang, Haojie
Published in Oncotarget (2016)

Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer

by Ma, Linlin, Yan, Yuqian, Bai, Yang, Yang, Yinhui, Pan, Yunqian, Gang, Xiaokun, Karnes, R. Jeffrey, Zhang, Jun, Lv, Qiubo, Wu, Qiang, Huang, Haojie
Published in Theranostics (2019)

RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis

by Bai, Yang, Yang, Yinhui, Yan, Yuqian, Zhong, Jian, Blee, Alexandra M., Pan, Yunqian, Ma, Tao, Karnes, R. Jeffrey, Jimenez, Rafael, Xu, Wanhai, Huang, Haojie
Published in Theranostics (2019)

P300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis

by Zhong, Jian, Ding, Liya, Bohrer, Laura R., Pan, Yunqian, Liu, Ping, Zhang, Jun, Sebo, Thomas J., Karnes, R. Jeffrey, Tindall, Donald J., van Deursen, Jan, Huang, Haojie
Published 2014

TMPRSS2-ERG controls luminal epithelial lineage and antiandrogen sensitivity in PTEN and TP53-mutated prostate cancer

by Blee, Alexandra M., He, Yundong, Yang, Yinhui, Ye, Zhenqing, Yan, Yuqian, Pan, Yunqian, Ma, Tao, Dugdale, Joseph, Kuehn, Emily, Kohli, Manish, Jimenez, Rafael, Chen, Yu, Xu, Wanhai, Wang, Liguo, Huang, Haojie
Published in Clin Cancer Res (2018)

PTEN loss promotes intratumoral androgen synthesis and tumor microenvironment remodeling via aberrant activation of RUNX2 in castration-resistant prostate cancer

by Yang, Yinhui, Bai, Yang, He, Yundong, Zhao, Yu, Chen, Jiaxiang, Ma, Linlin, Pan, Yunqian, Hinten, Michael, Zhang, Jun, Karnes, R. Jeffrey, Kohli, Manish, Westendorf, Jennifer J., Li, Benyi, Zhu, Runzhi, Huang, Haojie, Xu, Wanhai
Published in Clin Cancer Res (2017)

CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy

by Ding, Liya, Chen, Shuai, Liu, Ping, Pan, Yunqian, Zhong, Jian, Regan, Kevin M., Wang, Liguo, Yu, Chunrong, Rizzardi, Tony, Cheng, Liang, Zhang, Jun, Schmechel, Stephen C., Cheville, John C., van Deursen, Jan, Tindall, Donald J., Huang, Haojie
Published 2014

Loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion

by Yang, Yinhui, Blee, Alexandra M., Wang, Dejie, An, Jian, Pan, Yunqian, Yan, Yuqian, Ma, Tao, He, Yundong, Dugdale, Joseph, Hou, Xiaonan, Zhang, Jun, Weroha, S. John, Zhu, Wei-Guo, Wang, Y. Alan, DePinho, Ronald A., Xu, Wanhai, Huang, Haojie
Published in Cancer Res (2017)

The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer

by Yan, Yuqian, Ma, Jian, Wang, Dejie, Lin, Dong, Pang, Xiaodong, Wang, Shangqian, Zhao, Yu, Shi, Lei, Xue, Hui, Pan, Yunqian, Zhang, Jun, Wahlestedt, Claes, Giles, Francis J, Chen, Yu, Gleave, Martin E, Collins, Collin C, Ye, Dingwei, Wang, Yuzhuo, Huang, Haojie
Published in EMBO Mol Med (2019)